C
AGC Inc. ASGLF
$34.75 $5.0216.89% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

AGC Inc. is a Japan-based global manufacturing company specializing in glass, electronics, chemicals, and life science–related materials. The company operates across industrial, construction, automotive, display, semiconductor, and healthcare-related markets, supplying both materials and high-performance components. Its core revenue drivers are architectural and automotive glass, display glass substrates, electronic materials for semiconductors, and fluorochemical and specialty chemical products.

Founded in 1907 as Asahi Glass Co., the company was established to develop Japan’s domestic flat glass industry and reduce reliance on imports. Over more than a century, AGC evolved through industrialization, post-war reconstruction, and globalization into a diversified materials science company. In 2018, it rebranded as AGC Inc. to reflect its broader scope beyond glass, emphasizing advanced materials, electronics, and life sciences as strategic growth areas. The company is positioned as a technology-driven materials supplier with strengths in process engineering, scale manufacturing, and long-term customer integration.

Business Operations

AGC operates through four primary business segments: Glass, Electronics, Chemicals, and Life Science. The Glass segment includes architectural glass for buildings and Automotive Glass for vehicle manufacturers, generating stable, large-scale revenue tied to construction and automotive production cycles. The Electronics segment focuses on Display Glass, Electronic Materials, and semiconductor-related products, supplying critical substrates and materials used in flat-panel displays and advanced chip manufacturing.

The Chemicals segment produces fluorochemicals, chlor-alkali products, urethanes, and specialty chemicals used in industrial, environmental, and electronic applications. The Life Science segment encompasses biopharmaceutical contract development and manufacturing, including AGC Biologics, which provides biologics manufacturing services globally. AGC operates manufacturing and R&D facilities across Asia, Europe, and the Americas, with technologies ranging from float glass production to precision chemical synthesis and biologics manufacturing.

Strategic Position & Investments

AGC’s strategy emphasizes portfolio transformation toward high-value-added and growth-oriented businesses, particularly electronics materials and life sciences, while maintaining cash-generating legacy operations in glass and basic chemicals. The company has invested heavily in semiconductor-related materials, targeting demand driven by advanced logic, memory, and packaging technologies. It also prioritizes sustainability-focused innovations, including energy-efficient glass and environmentally advanced chemical processes.

A key strategic investment is AGC Biologics, which has expanded through capacity investments and acquisitions in Europe, the United States, and Asia to serve global biopharmaceutical customers. AGC has also pursued selective acquisitions in specialty chemicals and electronic materials to strengthen technological depth and customer relationships. Emerging focus areas include advanced semiconductor materials, next-generation display substrates, and biologics manufacturing technologies.

Geographic Footprint

AGC is headquartered in Tokyo, Japan, and operates a globally diversified manufacturing and commercial footprint. Its operations span Asia-Pacific, Europe, North America, and parts of Latin America, serving both regional and multinational customers. Japan remains a central hub for R&D and high-end manufacturing, particularly for advanced glass and electronic materials.

Internationally, AGC maintains significant production facilities in China, Southeast Asia, Germany, Belgium, Czech Republic, and the United States. Through its life sciences and electronics businesses, the company has built a strong international investment presence, supporting global pharmaceutical companies and semiconductor manufacturers with localized production and technical support.

Leadership & Governance

AGC is led by a management team emphasizing long-term value creation, technology leadership, and disciplined capital allocation. The leadership philosophy centers on balancing stable cash flow from mature businesses with strategic investment in growth areas aligned with global megatrends such as digitalization, sustainability, and healthcare.

Key executives include:

  • Toshinori IwatakePresident and Chief Executive Officer
  • Hiroshi YoshinagaChairman of the Board
  • Hideaki YamaneExecutive Vice President
  • Kazuhiko IshimuraExecutive Officer, Chemicals Business
  • Makoto OkadaExecutive Officer, Electronics Business

The company maintains a governance structure consistent with Japanese listed-company standards, with a board that includes independent directors and oversight aligned with shareholder and stakeholder interests.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $198.87
B
AAPL NASDAQ $266.43
B
AVGO NASDAQ $396.72
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $124.76
B
Top Financial Stocks
See All »
B
B
JPM NYSE $305.93
B
V NYSE $315.91
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $905.03
B
JNJ NYSE $238.67
B
AMGN NASDAQ $348.22
Top Real Estate Stocks
See All »
B
PLD NYSE $139.77